We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cameroon Mobile Phone SMS Trial (CAMPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01247181
Recruitment Status : Completed
First Posted : November 24, 2010
Last Update Posted : September 8, 2011
Sponsor:
Collaborator:
CIHR Canadian HIV Trials Network
Information provided by (Responsible Party):
Lawrence Mbuagbaw, Yaounde Central Hospital

Brief Summary:
The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.

Condition or disease Intervention/treatment
Adherence HIV Other: Mobile phone text message Other: Usual care

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Improving Adherence to HAART Using Mobile Phone Text Messages
Study Start Date : November 2010
Primary Completion Date : July 2011
Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Mobile phone text message Other: Mobile phone text message
Weekly message with motivational content
Other Names:
  • SMS
  • Texto
  • Text message
Active Comparator: No Mobile phone text message
Usual care provided at clinic
Other: Usual care
Usual care provided at clinic
Other Name: Routine care



Primary Outcome Measures :
  1. Adherence [ Time Frame: Change from baseline at 6 months ]
    Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data


Secondary Outcome Measures :
  1. Weight [ Time Frame: Change from baseline at 6 months ]
  2. Body Mass Index [ Time Frame: Change from baseline at 6 months ]
  3. CDC classification [ Time Frame: Change from baseline at 6 months ]
  4. WHO Classification [ Time Frame: Change from baseline at 6 months ]
  5. Mortality [ Time Frame: 6 months ]
    All cause mortality

  6. CD4 count [ Time Frame: Change from baseline at 6 months ]
  7. Viral load [ Time Frame: Change from baseline at 6 months ]
  8. Quality of life [ Time Frame: Change from baseline at 6 months ]
    Measured using the SF-12 quality of life form



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • On HAART for at least 1 month
  • 21 years or more
  • Owns a mobile phone
  • Can read text messages

Exclusion Criteria:

  • On HAART for less than 1 month
  • Aged less than 21 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01247181


Locations
Cameroon
Yaounde Central Hospital Accredited Treatment Centre
Yaounde, Centre, Cameroon
Sponsors and Collaborators
Yaounde Central Hospital
CIHR Canadian HIV Trials Network
Investigators
Principal Investigator: Lawrence Mbuagbaw, MD, MPH Centre for the Development of Best Practices in Health
Study Director: Pierre Ongolo-Zogo, MD, BSc Centre for the Development of Best Practices in Health

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lawrence Mbuagbaw, MD, MPH, Yaounde Central Hospital
ClinicalTrials.gov Identifier: NCT01247181     History of Changes
Other Study ID Numbers: CAMPS
PACTR201011000261458 ( Registry Identifier: Pan-African Clinical Trials Registry )
First Posted: November 24, 2010    Key Record Dates
Last Update Posted: September 8, 2011
Last Verified: September 2011

Keywords provided by Lawrence Mbuagbaw, Yaounde Central Hospital:
compliance
observance
mobile phone
SMS
text message
ARV
HAART
AIDS